Viking stays in obesity drug race with early data for weight loss pill
Bio Pharma Dive
MARCH 26, 2024
The results are from a small Phase 1 study, but suggest Viking’s oral GLP-1 drug may not come with high rates of gastrointestinal side effects.
Tue.Mar 26, 2024
299 
US FDA grants approval for Alexion’s NMOSD treatment
Pharmaceutical Technology
MARCH 26, 2024
The US FDA has approved Alexion’s Ultomiris to treat adults with AQP4 Ab+ neuromyelitis optica spectrum disorder (NMOSD).
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA approves Merck lung disease drug acquired in $11B deal
Bio Pharma Dive
MARCH 26, 2024
Merck is couting on Winrevair, which it acquired by buying Acceleron Pharma, to help soften the blow when Keytruda loses patent protection later this decade.
Astellas secures approval for gastric cancer antibody in Japan
Pharmaceutical Technology
MARCH 26, 2024
The approval from Japan’s Ministry of Health, Labour, and Welfare (MHLW) is based on positive results from two studies.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
SQZ, Portal founder Armon Sharei on starting over in biotech
Bio Pharma Dive
MARCH 26, 2024
After his first biotech startup was sold off in parts, Sharei is applying the lessons he’s learned to a new company with a different business model.
GlycoMimetics files patent for treating cancer and related conditions with compound of formula (i)
Pharmaceutical Technology
MARCH 26, 2024
Discover GlycoMimetics Inc.'s groundbreaking patent for treating cancer and related conditions with Formula (I) compound. Learn how this method can reduce chemotherapy side effects and improve patient outcomes.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Ingersoll Rand to expand life science presence with $2.3bn ILC buyout
Pharmaceutical Technology
MARCH 26, 2024
Ingersoll Rand has signed an agreement for the acquisition of ILC Dover for an upfront cash purchase price of approximately $2.325bn.
Researchers identify group of biological markers found in high levels in TB patients
Pharma Times
MARCH 26, 2024
According to the World Health Organization, TB is responsible for over one million annual deaths
Amneal gains FDA greenlight to develop Ciprodex generic for ear infections
Pharmaceutical Technology
MARCH 26, 2024
Novartis’ Ciprodex is a ciprofloxacin and dexamethasone otic suspension indicated to treat middle and outer bacterial ear infections.
Inizio Engage and Applied Driving partner to support clinical workers with safety app
Pharma Times
MARCH 26, 2024
The Companion+ Mobile Safety App will be rolled out to a further 115 users within the UK and US
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Experts flag concerns with drug compliance in osteoporosis landscape
Pharmaceutical Technology
MARCH 26, 2024
KOLs interviewed by GlobalData emphasised urgent action to address inconsistent drug compliance rates in the osteoporosis disease landscape.
Nanoscope preps filing for retinitis pigmentosa gene therapy
pharmaphorum
MARCH 26, 2024
Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying genetic mutations.
Regeneron hit with FDA rejection for blood cancer therapy
Pharmaceutical Technology
MARCH 26, 2024
The agency said it required the confirmatory portion of odronextamab’s Phase III trial.
Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
Fierce Pharma
MARCH 26, 2024
After three years, the crown jewel of Merck’s $11.5 billion acqu | After three years, the crown jewel of Merck’s $11.5 billion acquisition of Acceleron is ready to pay dividends. With the FDA’s approval of Winrevair (sotatercept) to treat pulmonary arterial hypertension (PAH), Merck is set to launch the first disease-modifying treatment for the condition.
Innovent Biologics files patent for patent filed for novel heterodimeric fc scaffold proteins
Pharmaceutical Technology
MARCH 26, 2024
Discover Innovent Biologics' groundbreaking patent for novel proteins with heterodimeric antibody Fc, revolutionizing antibody engineering and drug development.
Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment
BioSpace
MARCH 26, 2024
While Pfizer has ended one of its two Phase III studies for inclacumab in sickle cell disease, the company is still eyeing an approval for the antibody in the inherited blood disorder by 2026.
Syros Pharmaceuticals files patent for treating cancer with compound of formula (i)
Pharmaceutical Technology
MARCH 26, 2024
Discover Syros Pharmaceuticals' groundbreaking patent for treating cancer by targeting CDK7 with compounds of Formula (I). Learn about the innovative method and potential new treatment options for solid tumors.
Female leadership and lessening disease burden
pharmaphorum
MARCH 26, 2024
As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessening the burden of disease in LMICs.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Nurix Therapeutics files patent for bifunctional compounds for hpk1 degradation in disease treatment
Pharmaceutical Technology
MARCH 26, 2024
Discover how Nurix Therapeutics' patent for bifunctional compounds targeting HPK1 activity offers a groundbreaking method for treating diseases, including cancer. Learn more about this innovative approach in pharmaceutical compositions.
Aduhelm and an expensive failure to launch
pharmaphorum
MARCH 26, 2024
Aduhelm (aducanumab) and Leqembi are examples of controversial drugs that faced challenges with FDA approval. Learn more about the expensive failure to launch of these medications.
Pfizer files patent for multi-drug antibody drug conjugates with site-specific construction
Pharmaceutical Technology
MARCH 26, 2024
Discover Pfizer's innovative patent for multi-drug Antibody Drug Conjugates and Linking Assembly Units, enabling precise and effective drug delivery. Explore the cutting-edge technology behind site-specific construction and versatile drug linking options.
Reuters Pharma USA 2024 - Day 1
pharmaphorum
MARCH 26, 2024
Get live coverage of the latest updates and developments from Day 1 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.
Sanofi files patent for method for high-level expression of multiple target polypeptides
Pharmaceutical Technology
MARCH 26, 2024
Discover Sanofi's innovative patent for expressing multiple target polypeptides in mammalian cells using unique cell surface markers. This method could revolutionize protein expression technologies.
Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program
BioSpace
MARCH 26, 2024
Moderna has entered into a development and commercialization funding agreement with asset management firm Blackstone Life Sciences to help advance its pipeline of flu vaccine candidates.
Genmab files patent for treatment of diffuse large B-cell lymphoma using bispecific antibody
Pharmaceutical Technology
MARCH 26, 2024
Discover Genmab AS's innovative patent for treating DLBCL with a bispecific antibody and R-CHOP regimen. Learn about specific dosages and administration schedules for improved patient outcomes.
Nuvation Bio nears commercial stage with AnHeart buy
pharmaphorum
MARCH 26, 2024
Nuvation Bio speeds up its path to becoming a commercial-stage biotech with a deal to acquire AnHeart Therapeutics and its late-stage lung cancer therapy taletrectinib
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Bicycle Therapeutics files patent for method for determining cyclisation extent of peptide ligand
Pharmaceutical Technology
MARCH 26, 2024
Discover how Bicycle Therapeutics Plc's patent revolutionizes peptide cyclisation analysis on genetic display systems. Learn more about this innovative method now!
MSD leaps on FDA approval of PAH drug sotatercept
pharmaphorum
MARCH 26, 2024
MSD’s Winrevair (sotatercept) has become the first FDA-approved therapy for PAH that addresses the underlying mechanism behind the disease rather than its symptoms
Arcturus Therapeutics files patent for modified human otc protein for treating OTC deficiency
Pharmaceutical Technology
MARCH 26, 2024
Discover how Arcturus Therapeutics' patent for a modified human OTC protein revolutionizes OTC deficiency treatment with codon optimized mRNA sequences.
Caring Cross, Brazil's Fiocruz team up to produce cell and gene therapies at a fraction of their cost in the US
Fierce Pharma
MARCH 26, 2024
Maryland non-profit Caring Cross has unveiled a partnership with the Brazilian government that's designed to provide access to advanced cell and gene therapies for diseases like leukemia, lymphoma | Maryland nonprofit Caring Cross has unveiled a partnership with the Brazilian government which is designed to provide access to advanced CAR-T and gene therapies for diseases like leukemia, lymphoma and HIV infection—and in the process provide a manufacturing model that demonstrates how to reduc
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content